概述
The global health burden of diabetes is on the rise and has affected more than half a billion people worldwide, particularly in Southeast
Asia, North Africa, Africa, and the Western Pacific, Middle East, and South and Central America regions of the International Diabetes Federation (IDF). Despite many new treatments being available for the management of diabetes, glycemic control remains suboptimal in Asia,
compared to the rest of the world. Delay in timely insulin initiation and inadequate titration of insulin are regarded to be some of the
important reasons for inadequate glycemic control.